CGEM · ISSUER CIK 1789972
Cullinan Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Cullinan Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $780K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$780KInsider selling
−$780KNet open-market
Sep 10, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 202609:22 | Sep 8, 2026 | CGEM | Chief Scientific Officer | S · Sell10b5-1 | $21.57 | −8,000 | 158,844 | -5% | −$173K | ||
| Sep 10, 202609:22 | Sep 8, 2026 | CGEM | Chief Scientific Officer | M · Exercise10b5-1 | $4.30 | +4,000 | 166,844 | +2% | $17K | ||
| Aug 14, 202617:00 | Aug 13, 2026 | CGEM | Chief Scientific Officer | S · Sell10b5-1 | $20.26 | −30,000 | 162,844 | -16% | −$608K | ||
| Aug 14, 202617:00 | Aug 13, 2026 | CGEM | Chief Scientific Officer | M · Exercise10b5-1 | $4.30 | +30,000 | 192,844 | +18% | $129K |